Page 2 - Adial Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adial pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adial Pharmaceutical Today - Breaking & Trending Today

Smurfit Kappa Group (OTCMKTS:SMFTF) Trading Up 1.4%

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research upped their Q2 2023 earnings per share estimates for Adial Pharmaceuticals in a report released on Thursday, May 18th. Litchfield Hills Research analyst T. O’neill now expects that the company will post earnings of ($0.09) per share for the quarter, […] ....

Adial Pharmaceuticals Trading Down , Virtu Financial , Susquehanna International Group , Manchester Capital Management , Litchfield Hills Research , Citadel Advisors , Adial Pharmaceuticals Company Profile , News Ratings For Adial Pharmaceuticals Daily , Adial Pharmaceuticals Inc , Adial Pharmaceuticals , Renaissance Technologies , Get Rating , Hills Research , Adial Pharmaceutical , Pharmaceuticals Trading Down , Capital Management , International Group , Adial Pharmaceuticals Daily , Nasdaq Adil , Earnings Estimates ,

Adial Pharmaceuticals, Inc. Expected to Post FY2023 Earnings of ($0.49) Per Share (NASDAQ:ADIL)

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research issued their FY2023 EPS estimates for Adial Pharmaceuticals in a report released on Monday, April 3rd. Litchfield Hills Research analyst T. O’neill anticipates that the company will earn ($0.49) per share for the year. The consensus estimate for Adial Pharmaceuticals’ […] ....

Bankolea Johnson , Adial Pharmaceuticals Price Performance , Renaissance Technologies , Empirical Financial Services , Millennium Management , Citadel Advisors , Institutional Trading Of Adial Pharmaceuticals , Litchfield Hills Research , Adial Pharmaceuticals , News Ratings For Adial Pharmaceuticals Daily , Adial Pharmaceuticals Inc , Virtu Financial , Get Rating , Hills Research , Adial Pharmaceutical , Financial Services , Empirical Wealth Management , Adial Pharmaceuticals Daily , Nasdaq Adil , Earnings Estimates ,

Brokerages Expect Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Will Announce Earnings of -$0.17 Per Share

Wall Street analysts expect that Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) will report earnings of ($0.17) per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for Adial Pharmaceuticals’ earnings. Adial Pharmaceuticals reported earnings per share of ($0.30) in the same quarter last year, which suggests a positive year-over-year […] ....

Adial Pharmaceuticals Inc , Geode Capital Management , Zacks Investment Research , Commonwealth Equity Services , Adial Pharmaceuticals Company Profile Get Rating , Northrock Partners , Oppenheimer Co , Adial Pharmaceuticals , Millennium Management , Wall Street , Get Rating , Adial Pharmaceutical , Investment Research , Equity Services , Capital Management , Rock Partners , Pharmaceuticals Company Profile , Nasdaq Adil ,

Zacks: Analysts Expect Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Will Post Earnings of -$0.21 Per Share

Equities research analysts forecast that Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) will report earnings per share (EPS) of ($0.21) for the current quarter, according to Zacks. Zero analysts have provided estimates for Adial Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.21) and the highest is ($0.20). Adial Pharmaceuticals posted earnings of ($0.24) per share […] ....

Adial Pharmaceuticals Inc , Morgan Stanley , Geode Capital Management , Zacks Investment Research , Blackrock Inc , Adial Pharmaceuticals Company Profile Get Rating , Vanguard Group Inc , Litchfield Hills Research , Adial Pharmaceuticals , Get Rating , Adial Pharmaceutical , Investment Research , Hills Research , Street Corp , Capital Management , Pharmaceuticals Company Profile , Nasdaq Adil ,

Adial Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Adial Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

William Stilley , David Waldman Natalya Rudman , Adial Pharmaceuticals Inc , Crescendo Communications , Adial Pharmaceuticals , Chief Executive Officer , Annual Global Investment Conference , Adial Pharmaceutical , Alcohol Use Disorder , Opioid Use Disorder ,